Events9th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2023-15720 (registering DOI)
This submission belongs to the session S5. Natural Products and Biopharmaceuticals of the event 9th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2023
Academic Editor
author-avatarAlfredo Berzal-Herranz
Citation
Nataliia Melnichuk, Krzysztof Drabikowski, Igor Zhukov, Zenoviy Tkachuk, Complexes of oligoribonucleotides with D-mannitol inhibit the interaction of SARS-CoV-2 Spike pseudotyped lentiviral particles with host cells , in Proceedings of 9th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2023, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2023-15720
Share
Email
Facebook
Twitter
LinkedIn

Complexes of oligoribonucleotides with D-mannitol inhibit the interaction of SARS-CoV-2 Spike pseudotyped lentiviral particles with host cells

Krzysztof Drabikowski 2
1. Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine, Ukraine
2. Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland, Poland
Abstract

Coronavirus disease 2019 (COVID­-19) is a respiratory illness that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-­CoV-­2) and leads to numerous deaths. SARS-CoV-2 enters cells using its Spike protein, which is also a prospective target for the development of new anti-COVID­-19 drugs. Therefore, searching for novel therapeutic agents with Spike inhibitory activity is an urgent task. Oligoribonucleotides-D-mannitol (ORNs-D-M) complexes possess antiviral activity by inhibiting the activity of surface viral proteins. We hypothesized that the ORNs-D-M could inhibit SARS­-CoV­-2 Spike activity. Because SARS-CoV-2 is a biosafety-level-3 virus, one way to simplify such assays is to pseudotype biosafety-level-2 viral particles with Spike. In this study, we aimed to evaluate the ORNs-D-M efficiency against pseudotyped lentiviral particles with SARS-CoV-2 Spike.

We obtained SARS-CoV-2 Spike-pseudotyped lentiviral particles (Spike-pseudovirus) by transfecting the 293T cells with a plasmid complex (lentiviral backbone (Luciferase-IRES-ZsGreenbackbone), Spike SARS-CoV-2 and the other HIV proteins needed for virion formation). Microscope images showed the ZsGreen expression in the infected 293T-ACE2 cells with Spike-pseudovirus. Low ZsGreen fluorescence was observed in the infected 293T-ACE2 cells with Spike-pseudoviruses that were pre-incubated with the ORNs-D-M compared to the Spike-pseudovirus control. Luciferase expression was indicated in the infected 293T-ACE2 cells with Spike-pseudovirus. It was found that pre-incubation of the Spike-pseudovirus with the ORNs-D-M significantly reduced luciferase activity compared to the Spike-pseudovirus control. Decreased expression of ZsGreen and luciferase, marker proteins of cell infection with Spike-pseudovirus, potentially indicates that the ORNs-D-M interact with SARS-CoV-2 Spike and inhibit the interaction of Spike-pseudovirus with host cells. The obtained results show that the ORNs-D-M can have anti-COVID-­19 activity.

Keywords
Oligoribonucleotides with D-mannitol
SARS-CoV-2
Spike pseudotyped lentiviral particles
Manuscript
Toxicity studies, Hypoglycaemic activity of Cupressus torulosa needles and recognition of active molecules
Novel anthranilic acid hybrids – an alternative weapon against inflammatory pathologies